Acropolis Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $538K | Buy |
1,487
+4
| +0.3% | +$1.37K | 0.02% | 180 |
|
|
2026
Q1 | $522K | Buy |
1,483
+9
| +0.6% | +$3.21K | 0.02% | 177 |
|
|
2025
Q4 | $483K | Buy |
1,474
+233
| +19% | +$73.9K | 0.02% | 177 |
|
|
2025
Q3 | $346K | Buy |
1,241
+175
| +16% | +$50.8K | 0.02% | 209 |
|
|
2025
Q2 | $298K | Sell |
1,066
-31
| -3% | -$8.78K | 0.02% | 201 |
|
|
2025
Q1 | $342K | Buy |
1,097
+79
| +8% | +$23.3K | 0.02% | 176 |
|
|
2024
Q4 | $265K | Buy |
1,018
+1
| +0.1% | +$297 | 0.02% | 205 |
|
|
2024
Q3 | $328K | Hold |
1,017
| – | – | 0.02% | 182 |
|
|
2024
Q2 | $318K | Buy |
1,017
+18
| +2% | +$5.29K | 0.02% | 179 |
|
|
2024
Q1 | $284K | Hold |
999
| – | – | 0.02% | 188 |
|
|
2023
Q4 | $288K | Buy |
999
+34
| +4% | +$9.26K | 0.02% | 184 |
|
|
2023
Q3 | $259K | Buy |
965
+3
| +0.3% | +$749 | 0.02% | 192 |
|
|
2023
Q2 | $214K | Sell |
962
-15
| -2% | -$3.48K | 0.02% | 193 |
|
|
2023
Q1 | $236K | Sell |
977
-4
| -0.4% | -$982 | 0.02% | 187 |
|
|
2022
Q4 | $258K | Buy |
981
+15
| +2% | +$4.02K | 0.02% | 174 |
|
|
2022
Q3 | $218K | Sell |
966
-16
| -2% | -$3.88K | 0.02% | 179 |
|
|
2022
Q2 | $239K | Buy |
982
+16
| +2% | +$3.92K | 0.02% | 174 |
|
|
2022
Q1 | $234K | Sell |
966
-100
| -9% | -$23K | 0.02% | 172 |
|
|
2021
Q4 | $240K | Buy |
1,066
+15
| +1% | +$3.17K | 0.02% | 172 |
|
|
2021
Q3 | $223K | Sell |
1,051
-20
| -2% | -$4.6K | 0.03% | 170 |
|
|
2021
Q2 | $261K | Hold |
1,071
| – | – | 0.03% | 159 |
|
|
2021
Q1 | $266K | Sell |
1,071
-6
| -0.6% | -$1.43K | 0.03% | 154 |
|
|
2020
Q4 | $248K | Buy |
1,077
+86
| +9% | +$19.8K | 0.03% | 154 |
|
|
2020
Q3 | $252K | Hold |
991
| – | – | 0.03% | 143 |
|
|
2020
Q2 | $234K | Buy |
991
+16
| +2% | +$3.65K | 0.03% | 140 |
|
|
2020
Q1 | $198K | Buy |
+975
| New | +$213K | 0.03% | 135 |
|
|
2015
Q2 | – | Sell |
-655
| Closed | -$105K | – | 131 |
|
|
2015
Q1 | $105K | Hold |
655
| – | – | 0.02% | 144 |
|
|
2014
Q4 | $104K | Buy |
+655
| New | +$102K | 0.02% | 143 |
|
|
2014
Q3 | – | Sell |
-1,380
| Closed | -$163K | – | 145 |
|
|
2014
Q2 | $163K | Sell |
1,380
-700
| -34% | -$81K | 0.03% | 123 |
|
|
2014
Q1 | $257K | Sell |
2,080
-12,113
| -85% | -$1.47M | 0.05% | 102 |
|
|
2013
Q4 | $1.62M | Sell |
14,193
-823
| -5% | -$93.6K | 0.35% | 45 |
|
|
2013
Q3 | $1.68M | Sell |
15,016
-715
| -5% | -$77.5K | 0.35% | 45 |
|
|
2013
Q2 | $1.55M | Buy |
+15,731
| New | +$1.63M | 0.34% | 48 |
|
Other funds holding AMGN
FFM
Acropolis Investment Management's AMGN Position: Q2 2026 in Review
Acropolis Investment Management increased its Amgen (AMGN) stake by 0.27% in Q2 2026, buying an estimated $1.37K and bringing the position to 1,487 shares worth $538K. The position accounts for 0.02% of the portfolio, ranked #180.
Acropolis Investment Management first reported a position in AMGN in Q2 2013 and has held it in 33 quarters since. The position peaked at $1.68M in Q3 2013. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Acropolis Investment Management held 1,487 shares of Amgen worth $538K as of Q2 2026.
- Acropolis Investment Management bought 4 Amgen shares in Q2 2026, an estimated $1.37K.
- Amgen made up 0.02% of Acropolis Investment Management's portfolio in Q2 2026, its #180 holding.
- Acropolis Investment Management first reported a position in Amgen in Q2 2013 and has held it in 33 quarters since.
- Acropolis Investment Management's Amgen position peaked at $1.68M in Q3 2013.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Acropolis Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.